The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial
(By Scott Hensley, Jon Hamilton, and Laurel Wamsley for NPR) The Food and Drug Administration approved the drug aducanumab to
Read More
Questions to ask after you receive the diagnosis of Alzheimer’s
Hearing the diagnosis of Alzheimer’s disease is difficult to absorb, but once the diagnosis sinks in, it is a good
Read MoreFairness in Orphan Drug Exclusivity Act
The House passed the Fairness in Orphan Drug Exclusivity Act (H.R. 1629) to fix the nation’s orphan drug development rules
Read MoreTransitional apartments help Vets prepare for independent living
(Source – blogs.va.gov) “Beyond dreams!” That is how Marine Corps Veteran Rickey Ginn described his newly renovated transitional residence apartment
Read More1 in 3 Americans said access to affordable healthcare top barrier for well-being
(By Hannah Mitchell for Becker’s Hospital Review) Access to affordable healthcare is a top concern for a third of Americans,
Read MoreWill Medicare save you money
Millions of Americans are still working at age 65, and they are confused about signing up for Medicare. The decision
Read MoreWhy are Medicare Part D enrollees paying thousands for specialty drugs?
(By Katie Adams for Becker’s Hospital Review) Medicare is not providing adequate cost savings for the millions of Americans who take
Read MorePatient room location may have direct effects on patient satisfaction, Yale study finds
(By Hannah Mitchell for Becker’s Hospital Review) Researchers from New Haven, Conn.-based Yale University, the University of Wisconsin-Madison and the Philadelphia-based
Read MoreFDA Weighs Approval of a Lucrative Alzheimer’s Drug but Benefits Are Iffy
(By Harris Meyer for Kaiser Health News) The Food and Drug Administration’s decision next week whether to approve the first
Read MoreThe rules for Medicare enrollment when you are still working
If you are 65 and still working, the rules for Medicare enrollment will depend partly on whether your employer is
Read More